Physician profile
Timothy P Dailey
NPI 1164432399
$1,143.50
in general payments reported to CMS, 2019-2025
16 companies · $52.52 in 2025
The $52.52 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $265 · 2021: $172 · 2022: $220 · 2023: $116 · 2024: $17.73 · 2025: $52.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $510.81 | 2019-2023 | Mounjaro |
| Gilead Sciences, INC. | $135.88 | 2019-2021 | |
| Novo Nordisk INC | $85.61 | 2019-2023 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.01 | 2020-2025 | Jardiance |
| Eisai INC. | $49.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $47.73 | 2022-2024 | Breztri |
| Amgen INC. | $47.36 | 2022-2025 | Evenity, Otezla, Repatha |
| Exact Sciences Corporation | $36.88 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $33.96 | 2019-2023 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.63 | 2022 | |
| Pfizer INC. | $18.68 | 2019 | |
| Ibsa Pharma INC. | $17.91 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.98 | 2025 | Rexulti |
| Shire North American Group INC | $16.13 | 2019 | |
| Mckesson Medical-Surgical, INC. | $15.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $13.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.